Abstracts from the Abstracts from the Mid-Atlantic Section of the AUA 2021

MA-AUA 2021 Abstracts Moderated Poster Session 3: BPH/Urodynamics The Underachieving Results for Overactive Bladder T. Trump, Z. Werner, R. Shapiro, S. Zaslau West Virginia University, Morgantown, WV, USA Introduction and Objective: Overactive bladder (OAB) is highly prevalent. 75%of patients admit to using Internet searches as a primary source for health information. With telemedicine on the rise, this is expected to increase. We aim to evaluate the readability of online resources for OAB treatment. Methods: Google and Bing were used to query “sacral neuromodulation,” “peripheral tibial nerve stimulation (PTNS),” and “bladder botox.” The first 20 results from each were assessed, representing over 90% of accessed search results. Duplicate websites, paid advertisements, and video only websites were excluded. Websites were categorized as either institutional/reference, commercial, non-profit, or personal. Three validated readability scores (Gunning-Fog (GF), SMOG, and Dale Chall (DC)) were used to assess the readability of these results and compared to the National Institutes of Health recommended grade 6-7 level. Results: Sacral neuromodulation yielded 27 eligible results .The mean score for GF, SMOG, and DS (with standard deviation) were: 16.0 (3.14), 11.9 (2.10), and 9.7 (0.87), respectively. These correlate to levels of college senior, high school junior and college level. PTNS yielded 31 eligible results. The mean score for GF, SMOG, and DS were: 16.7(3.38), 12.5 (2.42), and 9.7 (0.84), respectively. These correlate to levels of college senior, high school senior, and college level. Bladder botox yielded 17 eligible results. The mean score for GF, SMOG, and DS were: 13.9 (2.88), 10.3 (2.07), and 9.2 (0.84), respectively. These correlate to levels of college sophomore, high school junior, and college level. There was no difference between the therapy types in terms of readability. 61% of websites were institutional/reference, 24% commercial, 13% non- profit, and 2% personal. Institutional/reference tended to have higher scores although this was not significant. Conclusions: Information regarding OAB treatment is provided at a level difficult to interpret by the general population. These findings highlight a need for improvement in quality of online information. MRI Fusion Targeted Confirmatory Prostate Biopsy Improves the Selection of Men with Prostate Cancer for Active Surveillance Jeffrey Leow (1) , Soon Hock Koh (1) , Rolando Salada (1) , Seok Kwan Hong (1) , Yuyi Yeow (1) , Teck Wei Tan (1) (1) Tan Tock Seng Hospital Introduction andObjectives: Men on active surveillance for low-risk prostate cancer are recommended to undergo confirmatory biopsy within a year of diagnosis. The only randomised trial (ASIST trial) in this population failed to show an improvement in upgrading rates with targeted biopsy compared to systematic biopsy at the first confirmatory biopsy. We aim to evaluate our series of men on active surveillance who underwent concurrent systematic and MRI fusion targeted confirmatory biopsy. Methods: From our prospectively maintained MRI fusion targeted biopsy database at our institution, we identified patients on active surveillance who underwent biopsy fromMay 2016 to Dec 2019. Inclusion criteria for our study were patients with at least one Prostate Imaging Reporting and Data System (PI-RADS) ≥ 3 lesion, and who underwent targeted and systematic biopsies. Upgrading was defined as any newly detected clinically significant prostate cancer (csPCa) of Gleason grade group ≥ 2. Results: A total of 61 patients were identified, with a median age of 71 years (interquartile range [IQR] 67-75), median prostate-specific antigen of 7.26 ng/ml (IQR 5-10) and median Prostate Health Index (PHI) level of 34.5 (IQR 18-44). Upgrading to csPCa was found in 41% (n = 25) of patients. Targeted biopsies upgraded 9 (14.8%) patients who did not have csPCa with systematic confirmatory biopsy alone. Conclusions: MRI fusion targeted confirmatory biopsy upgrades a significant proportion of men with previous low-risk prostate cancer and improves the selection of patients suitable for active surveillance. MP3-12 MP3-11 23